Lonn EM - Search Results

1

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska O, Leong D, Anand SS, Störk S, Branch KRH, Bhatt DL, Verhamme PB, O'Donnell M, Maggioni AP, Lonn EM, Piegas LS, Ertl G, Keltai M, Bruns NC, Muehlhofer E, Dagenais GR, Kim JH, Hori M, Steg PG, Hart RG, Diaz R, Alings M, Widimsky P, Avezum A, Probstfield J, Zhu J, Liang Y, Lopez-Jaramillo P, Kakkar AK, Parkhomenko AN, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Vinereanu D, Tonkin AM, Lewis BS, Felix C, Yusoff K, Metsarinne KP, Fox KAA, Yusuf S; COMPASS Investigators. Moayyedi P, et al. Among authors: lonn em. Gastroenterology. 2019 Sep;157(3):682-691.e2. doi: 10.1053/j.gastro.2019.05.056. Epub 2019 May 29. Gastroenterology. 2019. PMID: 31152740 Clinical Trial.

2

The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data.

Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. Jha P, et al. Ann Intern Med. 1995 Dec 1;123(11):860-72. doi: 10.7326/0003-4819-123-11-199512010-00009. Ann Intern Med. 1995. PMID: 7486470 Review.

3

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

Lonn EM, Yusuf S, Jha P, Montague TJ, Teo KK, Benedict CR, Pitt B. Lonn EM, et al. Circulation. 1994 Oct;90(4):2056-69. doi: 10.1161/01.cir.90.4.2056. Circulation. 1994. PMID: 7923694 Review. No abstract available.

4

Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.

Yusuf S, Lessem J, Jha P, Lonn E. Yusuf S, et al. J Hypertens Suppl. 1993 Jun;11(4):S61-73. J Hypertens Suppl. 1993. PMID: 8104243 Review.

5

Effects of ACE inhibitors on mortality when started in the early phase of myocardial infarction: evidence from the larger randomized controlled trials.

Flather MD, Lonn EM, Yusuf S. Flather MD, et al. Among authors: lonn em. J Cardiovasc Risk. 1995 Oct;2(5):423-8. doi: 10.1177/174182679500200506. J Cardiovasc Risk. 1995. PMID: 8749269 Review.

6

Study design and baseline characteristics of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E: SECURE.

Lonn EM, Yusuf S, Doris CI, Sabine MJ, Dzavik V, Hutchison K, Riley WA, Tucker J, Pogue J, Taylor W. Lonn EM, et al. Am J Cardiol. 1996 Oct 15;78(8):914-9. doi: 10.1016/s0002-9149(96)00467-5. Am J Cardiol. 1996. PMID: 8888665 Clinical Trial.

7

Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data.

Lonn EM, Yusuf S. Lonn EM, et al. Can J Cardiol. 1997 Oct;13(10):957-65. Can J Cardiol. 1997. PMID: 9374952 Review.

8

Anti-ischaemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials.

Yusuf S, Lonn E. Yusuf S, et al. Eur Heart J. 1998 Sep;19 Suppl J:J36-44. Eur Heart J. 1998. PMID: 9796839 Review.

9

The Study of Health Assessment and Risk in Ethnic groups (SHARE): rationale and design. The SHARE Investigators.

Anand SS, Yusuf S, Vuksan V, Devanesen S, Montague P, Kelemen L, Bosch J, Sigouin C, Teo KK, Lonn E, Gerstein HC, Hegele RA, McQueen M. Anand SS, et al. Can J Cardiol. 1998 Nov;14(11):1349-57. Can J Cardiol. 1998. PMID: 9854515

10

Emerging approaches in the prevention of atherosclerotic cardiovascular diseases.

Lonn EM, Yusuf S. Lonn EM, et al. Int J Clin Pract Suppl. 1998 May;94:7-19. Int J Clin Pract Suppl. 1998. PMID: 9926440 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page